We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 853

Court awards $6.5 million for plaintiffs' costs following successful infringement action
  • Borden Ladner Gervais LLP
  • Canada
  • December 14 2016

The Court awarded the Plaintiffs a lump sum payment of $6.5 million for their costs in this case. The amount consisted of $2.9 million for legal fees


Original decision finding that the DOMAINE PINNACLE word and design mark is not confusing with the registered PINNACLES mark is restored on appeal
  • Borden Ladner Gervais LLP
  • Canada
  • December 14 2016

The Federal Court of Appeal has restored a decision of the Register of Trademarks that held that an application for a word and design


Motion to Dismiss NOC Proceeding Granted Non-Infringement as an Abuse of Process
  • Borden Ladner Gervais LLP
  • Canada
  • December 14 2016

Apotex's motion to dismiss Valeant's NOC Proceeding pursuant to s. 6(5)(b) of the NOC Regulations was granted with costs. Apotex's NOA alleged


Motion to amend Statement of Claim and motion for summary judgment allowed in part in copyright action
  • Borden Ladner Gervais LLP
  • Canada
  • December 14 2016

In the within action for copyright infringement, the Plaintiff claims to be the owner of the copyright in certain cinematographic works and unfixed


FCA dismisses appeal; upholds finding that obviousness allegations are justified
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2015

The Federal Court of Appeal (FCA) issued two sets of reasons stemming from two appeals between these companies. Both appeals were from the same


Court refuses prohibition order; finds allegations of non-infringement and obviousness justified
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2015

The Federal Court dismissed the proceeding, refusing to grant Lilly a prohibition order in relation to its formulation patent. The Court held that


Appeal dismissed; patent claims upheld as invalid due to obviousness
  • Borden Ladner Gervais LLP
  • Canada
  • July 29 2015

The Federal Court of Appeal (FCA) dismissed an appeal from a trial decision finding the claims at issue in a patent infringement case to be invalid


Patent is not found to be a selection patent, and thus was anticipated and obvious
  • Borden Ladner Gervais LLP
  • Canada
  • November 23 2015

The Federal Court has dismissed an application for prohibition to prevent the Minister of Health from issuing an NOC to Mylan for cinacalcet


Life Sciences Legal Trends In Canada
  • Borden Ladner Gervais LLP
  • Canada
  • June 20 2017

Life Sciences Legal Trends In Canada


Stay granted preventing issuance of NOC pending judicial review application for data protection
  • Borden Ladner Gervais LLP
  • Canada
  • July 15 2015

This is a motion by Horizon for an Order staying the issuance of a Notice of Compliance (NOC) to Horizon for its drug, pursuant to Sections 18(1), 18